The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Emerging role of nanosuspensions in drug delivery systems
Open accessAbstract
Rapid advancement in drug discovery process is leading to a number of potential new drug candidates having excellent drug efficacy but limited aqueous solubility. By virtue of the submicron particle size and distinct physicochemical properties, nanosuspension has the potential ability to tackle many formulation and drug delivery issues typically associated with poorly water and lipid soluble drugs. Conventional size reduction equipment such as media mill and high-pressure homogenizers and formulation approaches such as precipitation, emulsion-solvent evaporation, solvent diffusion and microemulsion techniques can be successfully implemented to prepare and scale-up nanosuspensions. Maintaining the stability in solution as well as in solid state, resuspendability without aggregation are the key factors to be considered for the successful production and scale-up of nanosuspensions. Due to the considerable enhancement of bioavailability, adaptability for surface modification and mucoadhesion for drug targeting have significantly expanded the scope of this novel formulation strategy. The application of nanosuspensions in different drug delivery systems such as oral, ocular, brain, topical, buccal, nasal and transdermal routes are currently undergoing extensive research. Oral drug delivery of nanosuspension with receptor mediated endocytosis has the promising ability to resolve most permeability limited absorption and hepatic first-pass metabolism related issues adversely affecting bioavailability. Advancement of enabling technologies such as nanosuspension can solve many formulation challenges currently faced among protein and peptide-based pharmaceuticals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
THE RATE OF SOLUTION OF SOLID SUBSTANCES IN THEIR OWN SOLUTIONS.
Noyes, A. A., & Whitney, W. R. (1897) · Journal of the American Chemical Society · doi:10.1021/ja02086a003 · Cited by 1,884
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Techniques for physicochemical characterization of nanomaterials
Lin, P.-C., Lin, S., Wang, P. C., & Sridhar, R. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.11.006 · Cited by 708
Nanosuspension: An approach to enhance solubility of drugs
Agrawal, Y., & Patel, V. (2011) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/2231-4040.82950 · Cited by 682
Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
Lamprecht, A., Schäfer, U., & Lehr, C.-M. (2001) · Pharmaceutical Research · doi:10.1023/a:1011032328064 · Cited by 507
Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration
Jacobs, C., & Müller, R. H. (2002) · Pharmaceutical Research · doi:10.1023/a:1014276917363 · Cited by 439
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372
Cited by
Emerging Role of Hydrogels in Drug Delivery Systems, Tissue Engineering and Wound Management
Jacob, S., Nair, A. B., Shah, J., Sreeharsha, N., Gupta, S., & Shinu, P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030357 · Cited by 485
Self-citationNanotechnology based drug delivery systems for the treatment of anterior segment eye diseases
Onugwu, A. L., Nwagwu, C. S., Onugwu, O. S., Echezona, A. C., Agbo, C. P., Ihim, S. A., Emeh, P., Nnamani, P. O., Attama, A. A., & Khutoryanskiy, V. V. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.018 · Cited by 350
Nanocarriers for ocular drug delivery: current status and translational opportunity
Gorantla, S., Rapalli, V. K., Waghule, T., Singh, P. P., Dubey, S. K., Saha, R. N., & Singhvi, G. (2020) · RSC Advances · doi:10.1039/d0ra04971a · Cited by 313
Li, B., Shao, H., Gao, L., Li, H., Sheng, H., & Zhu, L. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2094498 · Cited by 289
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 277
Metadata
- Authors
- Jacob, S., Nair, A. B., & Shah, J.
- Venue
- Biomaterials Research
- Published
- 2020-01-15
- Volume
- 24
- Issue
- 1
- Pages
- 3-3
- ISSN
- 1226-4601 (ISSN-L)
- 2055-7124
- OpenAlex
- W3007071961
- Cited by
- 415
- References
- 65
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emerging role of nanosuspensions in drug delivery systems. https://app.cochat.ai/papers/10.1186/s40824-020-0184-8
- The paper
- Jacob, S., Nair, A. B., & Shah, J. (2020). Emerging role of nanosuspensions in drug delivery systems. Biomaterials Research. https://doi.org/10.1186/s40824-020-0184-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.